HELP
Cybin D/B/A Helus Pharma
Set alert
10.60 USD -0.12 -1.07%
10.42 Day range 10.97
3.87 52-week range 14.02
- YTD
- +29.52%
- 1 year
- +47.56%
- Open
- 10.53
- Prev close
- 10.71
- Mkt cap
- 774.17M
- Vol
- 1.15M
- Avg vol
- 1.70M
- EPS
- -4.15
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.42
- High
- 10.97
- Forward P/E
- -7.55
- Beta
- 0.63
- Short ratio
- 1.59
- Inst. own
- 41.29%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 10.70
- 200-d avg
- 7.11
- 1y target
- 40.24
1Y chart
Closing price and volume
Compare HELP
Chart and line up HELP against other symbols or a saved comparison set.
- HELP Cybin D/B/A Helus Pharma
10.60
-0.12 -1.07%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | HELP | SPY | QQQ |
|---|---|---|---|
| Last price | 10.60 | 755.72 | 690.49 |
| Change | -0.115 | -13.64 | -24.85 |
| Change % | -1.07% | -1.77% | -3.47% |
| Open | 10.53 | 761.38 | 697.13 |
| Day high | 10.97 | 761.46 | 698.63 |
| Day low | 10.42 | 750.36 | 683.45 |
| Previous close | 10.71 | 769.36 | 715.34 |
| Volume | 1.15M | 77.70M | 85.24M |
| Average volume | 1.70M | 41.22M | 34.57M |
| Market cap | 774.17M | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -4.15 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 14.02 | 779.09 | 759.66 |
| 52-week low | 3.87 | 631.97 | 558.28 |
| 1-week return | +3.97% | -0.559233% | -1.97% |
| 1-month return | -13.79% | -0.906075% | -6.66% |
| 3-month return | +30.16% | +1.89% | +1.02% |
| 6-month return | +99.53% | +5.16% | +3.41% |
| Year-to-date return | +29.52% | +10.82% | +12.40% |
| 1-year return | +47.56% | +11.16% | +10.29% |
| 2-year return | +5.63% | +32.90% | +42.71% |
| 50-day moving average | 12.00 | 767.63 | 725.41 |
| 200-day moving average | 7.70 | 728.53 | 679.17 |
| Target price | 40.24 | — | — |
| Beta | 0.632 | 0.00 | 0.00 |
| Short ratio | 1.59 | — | — |
| Institutional ownership | 41.29% | — | — |